Skip to content

About
- Our Philosophy
- Team
Programs
Ventures
Press
Contact

Venture

SORT

Location

AllConnecticutNew York City

Program

AllABCTELabNYCThe Next Milestone

Attributes

AllWomen Founded

Affiliation

AllAlbert Einstein College of MedicineCity College of New YorkCity University of New YorkCold Spring Harbor LaboratoryColumbia UniversityHospital for Special SurgeryIcahn School of Medicine at Mount SinaiMemorial Sloan Kettering Cancer Center (MSKCC)Mount SinaiNew York UniversityNew York University Medical CenterNY Genome CenterPolytechnic Institute of New York UniversityQuinnipiac UniversityRockefeller UniversityState University of New York DownstateStevens Institute of TechnologySUNYUniversity of ConnecticutWeill Cornell Medical CollegeYale University

Technology

AllBioinformatics ToolChemical SensorsDiagnosticDigital Health TechnologyDx and RxFunctional Food and DrinksHealthcare ServicesImmunotherapyIT SystemsMedical DeviceNutraceuticalPharmaceutical DrugPlatform Technology for Rapid DevelopmentResearch ToolTherapeuticTransplantationVaccinesWearable Assistive Technology

Indication

AllAllergy/AsthmaAssistive footwearAutoimmune & InflammationBasic ResearchBiologicBiomaterialsBotanical Treatment for Keloid DisorderCardiovascular DiseaseCentral Nervous System DisordersClinical ResearchClinical TrialsDelivery MethodDentistryDermatologyDevelopmental DisordersDisease SurveillanceDisordersDrug CompositionDrug DiscoveryEducationFibrosisGenetics & GenomicsHardware/SoftwareHealthcare ManagementHematologyImmunotherapyInfectious DiseaseMaternal healthMedical ImagingMetabolic DiseaseMobile Health IT PlatformMolecular DiagnosticMusculoskeletal DisordersNanotechnologyNephrologyNeurodegenerative DiseaseNeurologyNew method of sequencing mitochondrial DNANutritionObesityOncologyOrphan DiseasesOrthopaedicsPain ManagementPersonalized MedicinePharmacoeconomicsPhysical TherapyPlatform TechnologyProduction ProcessRegenerative MedicineResearch toolsRespiratory DiseaseSmall molecular inhibitors of Rel/NF-kBSurgical ToolTransplantationTwo-way text message based patient engagement, medical therapy management and care coordination platform (enterprise level)VaccineWomen’s health

Affiliations

New York University

Technologies

Therapeutic

Indication

Oncology

Personalized Medicine

Website

TEZCAT is developing a biologics-based therapeutic approach to treat mutant Ras cancers, such as colorectal cancer.

TEZCAT team:

CEO – Alex Efron
CSO – Craig Ramirez, Ph.D.
Ops. Mgr – Andy Hauser, Ph.D.

SORT

Location

AllConnecticutNew York City

Program

AllABCTELabNYCThe Next Milestone

Attributes

AllWomen Founded

Affiliation

AllAlbert Einstein College of MedicineCity College of New YorkCity University of New YorkCold Spring Harbor LaboratoryColumbia UniversityHospital for Special SurgeryIcahn School of Medicine at Mount SinaiMemorial Sloan Kettering Cancer Center (MSKCC)Mount SinaiNew York UniversityNew York University Medical CenterNY Genome CenterPolytechnic Institute of New York UniversityQuinnipiac UniversityRockefeller UniversityState University of New York DownstateStevens Institute of TechnologySUNYUniversity of ConnecticutWeill Cornell Medical CollegeYale University

Technology

AllBioinformatics ToolChemical SensorsDiagnosticDigital Health TechnologyDx and RxFunctional Food and DrinksHealthcare ServicesImmunotherapyIT SystemsMedical DeviceNutraceuticalPharmaceutical DrugPlatform Technology for Rapid DevelopmentResearch ToolTherapeuticTransplantationVaccinesWearable Assistive Technology

Indication

AllAllergy/AsthmaAssistive footwearAutoimmune & InflammationBasic ResearchBiologicBiomaterialsBotanical Treatment for Keloid DisorderCardiovascular DiseaseCentral Nervous System DisordersClinical ResearchClinical TrialsDelivery MethodDentistryDermatologyDevelopmental DisordersDisease SurveillanceDisordersDrug CompositionDrug DiscoveryEducationFibrosisGenetics & GenomicsHardware/SoftwareHealthcare ManagementHematologyImmunotherapyInfectious DiseaseMaternal healthMedical ImagingMetabolic DiseaseMobile Health IT PlatformMolecular DiagnosticMusculoskeletal DisordersNanotechnologyNephrologyNeurodegenerative DiseaseNeurologyNew method of sequencing mitochondrial DNANutritionObesityOncologyOrphan DiseasesOrthopaedicsPain ManagementPersonalized MedicinePharmacoeconomicsPhysical TherapyPlatform TechnologyProduction ProcessRegenerative MedicineResearch toolsRespiratory DiseaseSmall molecular inhibitors of Rel/NF-kBSurgical ToolTransplantationTwo-way text message based patient engagement, medical therapy management and care coordination platform (enterprise level)VaccineWomen’s health

Quick Links

Newsletter Signup

Follow us

FXFLOGO_COLOR1-500

Our Affiliated Programs:

The-Catalyst_11-19-19-01-Biosciences-Accelerator

ABCT-logo_1x

Quick Links

Newsletter Signup

Follow us

FXFLOGO_COLOR1-500

Our Affiliated Programs:

The-Catalyst_11-19-19-01-Biosciences-Accelerator

ABCT-logo_1x

© 2025 FirstXFounder. All Rights Reserved. | Privacy Policy